EmmanuelBenjaminWalterMD

Pediatrics • Durham, NC

Professor, Pediatrics, Duke University School of Medicine Chief Medical Officer, Duke Human Vaccine Institute

Join to view full profile

Dr. Walter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Walter's full profile

Already have an account?

Office
Duke Vaccine and Trials Unit @ RTP
27 Alexandria Way
Durham, NC 27703
Phone+1 919-620-5346

Education & Training

Duke University HospitalResidency, Pediatrics, 1987 - 1990
University of MarylandResidency, Pediatrics, 1983 - 1987
University of Maryland School of MedicineClass of 1983

Certifications & Licensure

NC State Medical License 1987 - 2025
MD State Medical License 1984 - 1987
American Board of Pediatrics Pediatrics

Clinical Trials

Alternate Dosing Schedules Study for HPV Vaccine Start of enrollment: 2009 Mar 01
Completed
Phase 4
Home Administration of FluMist by Parents/Caregivers Start of enrollment: 2014 Sep 01
Completed
Not Applicable
Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV Start of enrollment: 2013 Oct 01
Completed
Phase 4
An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq) Start of enrollment: 2014 Feb 01
Completed
Phase 4
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine Start of enrollment: 2014 Sep 01
Completed
Not Applicable
Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever) Start of enrollment: 2015 Dec 29
Terminated
Phase 4
An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC) Start of enrollment: 2019 Feb 14
Completed
Presyncope (Syncope) Prevention Study Start of enrollment: 2021 Mar 10
Completed
Not Applicable
Observational Maternal COVID-19 Vaccination Study Start of enrollment: 2021 May 24
COMPLETED
A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults Start of enrollment: 2023 Apr 05
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Perceived feasibility of a multicomponent prenatal intervention on childhood vaccinations: Findings from a national cross-sectional survey of prenatal care providers, ...
Lavanya Vasudevan, Rachael M Porter, Sandra S Stinnett, Lauren Hart, Elizabeth L Turner
International Journal of Gynaecology and Obstetrics. 2025-03-27
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adju...
Theresa E Hegmann, Emmanuel B Walter, Michael J Smith, James Campbell, Hana M El Sahly
Vaccine. 2025-03-18
Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants: A Randomized Clinical Trial.
Rachel G Greenberg, Wes Rountree, Mary Allen Staat, Elizabeth P Schlaudecker, Brenda Poindexter
JAMA Pediatrics. 2025-03-01

Journal Articles

Reactogenicity and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant and Nonpregnant Women☆
Kimberly B Fortner, Geeta K Swamy, M Anthony Moody, Sandra Yoder, Kathryn M Edwards, Emmanuel B Walter, R Phillips Heine, ScienceDirect
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season
Emmanuel Walter, MD, Centers for Disease Control and Prevention

Press Mentions

Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu ShotsNovember 11th, 2024
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu ShotsNovember 8th, 2024
It’s Safe to Get the COVID-19 and Flu Shots at the Same TimeNovember 6th, 2024
Join now to see all

Grant Support

RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory SettingsDUKE UNIVERSITY2022–2027
RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory SettingsDUKE UNIVERSITY2022–2025
RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory SettingsDUKE UNIVERSITY2022–2025
Piiitch StudyNational Center For Immunization And Respiratory Diseases2006–2008